Under construction – not a live service
Sign in

NCT07655284WithdrawnPhase 3

STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy

STENT X Non-stent Genito-urinary Tract Reconstruction After Radical Cystectomy for Bladder Cancer - a Prospective, Randomized, Controlled and Multi Institutional Trial

Source: ClinicalTrials.gov · Last updated 13 Aug 2026

Reason given: Study withdrawn prior to enrollment. Principle Investigator changed institutions prior to obtaining IRB approval.

Brief summary (registry, in English)

Radical Cystectomy (RC) remains the gold standard for localized muscle-invasive bladder cancer (MIBC); however, use of ureteral stents at time of surgery remains controversial without level 1 evidence to comment on risks or benefits of their use. RC complications commonly include urinary tract infections (UTIs), pyelonephritis, ureteroileal leakage and stenosis, and can occur with either ileal conduit or orthotopic neobladder diversions. Traditionally, ureteral stents are thought to support anastomotic healing and reduce the risk of anastomotic leakage and strictures; however, emerging evidence from retrospective studies suggests that stent use may paradoxically increase rates of postoperative morbidity. This randomized, multicenter and prospective study aims to compare 30-day postoperative complication rates between stented and non-stented urinary diversions in patients undergoing RC for MIBC, in both ileal conduit or neobladder with either robotic or open approaches.

Status (registry)
Withdrawn
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
0 (actual)
First submitted
12 Jun 2026
Start date
1 Sept 2026
Primary completion date
30 Jun 2029
Lead sponsor
Brigham and Women's Hospital
NCT number
NCT07655284

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Simultaneous surgical procedures (except those specified in the inclusion criteria that are considered part of a routine radical cystectomy)
  • History of prior urinary diversion
  • Previous radiation therapy in the pelvis for any reason

Other illness

  • Cystectomy for other reasons than Bladder cancer

Other

  • Patients who decline to participate, lack understanding of the study's purpose, or are unable to provide informed consent
  • Extremely debilitated patients, malnourished individuals, or those undergoing palliative or hygienic cystectomy

Who the study is looking for

  • Adults (> 18 years old)
  • Muscle invasive bladder cancer or non-muscle invasive bladder cancer with indication of Radical Cystectomy
  • No concomitant surgeries like nephrectomies, colectomies or removal of other organs affected by the tumor (Except standard lymph node dissections as well as in men the prostate and seminal vesicles and in women the uterus, fallopian tubes, ovaries and vagina, that are considered part of the oncological radical cystectomy.)
  • Patients who have the capacity to understand the study procedures and provide written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Instituto do Cancer do Estado de Sao Paulo - ICESPSão PauloBrazilUnknown status
Brigham and Women's HospitalBostonUnited StatesUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.